SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037297
Filing Date
2020-08-06
Accepted
2020-08-06 08:32:14
Documents
65
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-10q_20200630.htm   iXBRL 10-Q 2367329
2 EX-31.1 kzr-ex311_6.htm EX-31.1 19902
3 EX-31.2 kzr-ex312_8.htm EX-31.2 20046
4 EX-32.1 kzr-ex321_7.htm EX-32.1 9200
5 GRAPHIC gbv5yg3wrdre000001.jpg GRAPHIC 29787
  Complete submission text file 0001564590-20-037297.txt   7790308

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kzr-20200630.xsd EX-101.SCH 47127
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzr-20200630_cal.xml EX-101.CAL 42735
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzr-20200630_def.xml EX-101.DEF 117807
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzr-20200630_lab.xml EX-101.LAB 348400
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzr-20200630_pre.xml EX-101.PRE 264239
11 EXTRACTED XBRL INSTANCE DOCUMENT kzr-10q_20200630_htm.xml XML 1506114
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 201079994
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences